Phobic Anxiety Diagnosed in 24.6% of Acne Outpatients

Evidence

A psychiatrist diagnosed phobic anxiety disorders—conditions involving marked fear of particular situations or objects—in 69 of 280 acne outpatients at one Hanoi dermatology hospital: 24.6%, with a 95% confidence interval of 20.0%–30.0%. Social phobia, involving fear in social situations, accounted for 64 participants: 22.9% of the full sample and 92.8% of those with phobic anxiety disorders.

The acne outpatient study, published September 10, 2026, used convenience sampling at a national dermatology hospital between December 2025 and June 2026. Its cross-sectional design assessed conditions and associated factors without following their development over time. Diagnoses used the International Classification of Diseases, 10th revision, clinical criteria. The Fear Questionnaire described symptoms among diagnosed cases rather than establishing diagnoses.

An exploratory statistical model reported the following associations. Adjusted odds ratios compare odds after accounting for other factors in the model; they are not multipliers of a person's probability of developing a disorder.

| Associated factor | Adjusted odds ratio | 95% confidence interval | |---|---:|---:| | Study-specific anxiety-proneness rating | 6.90 | 2.92–16.32 | | Coexisting physical illness | 4.70 | 2.30–9.60 | | Acne scarring | 2.29 | 1.04–5.05 | | Poor treatment response | 5.06 | 2.20–11.62 |

The breast-cancer study, published September 9, examined HER2-positive disease, characterized by elevated levels of the HER2 growth-signaling protein. It combined spatial maps of gene activity, measurements of molecules involved in metabolism, public gene-activity datasets, and cell and mouse experiments. Gene-activity sequencing of individual cell nuclei from four patient tumor tissues retained 2,294 nuclei after quality control.

The integrated analyses identified tumor-initiating cells marked by the proteins PROM1 and SMAD5, alongside two distinct populations of stromal cells—the supporting cells surrounding tumors. These were subgroups of fat cells and fibroblasts, which are connective-tissue cells. The two stromal populations promoted lung metastasis, or cancer spread to the lungs, in mice.

The study reported that these stromal populations activated EGFR, a growth-signaling receptor, through a process dependent on the protein COPA. This triggered a molecular pathway involving EGFR, SMAD5 and CYP3A4 in the identified tumor-initiating cells. It also reported that stromal cells released exosomes—small cellular packages—carrying miR-671-3p, a regulatory RNA molecule. This reduced the protein Claudin1 and promoted a Claudin1-negative cell population with more stem-cell-like properties and greater metastatic potential.

Analysis

Interpretation: The connection is measurement specificity, not a shared biological mechanism. Psychiatric diagnosis distinguishes defined anxiety disorders from broad distress; the cancer work connects particular cell populations and molecular signals to experimental behavior. The prevalence estimate directly describes a sampled clinical population, while the metastasis findings support a proposed mechanism within one integrated research program. Multiple methods within that program do not constitute independent confirmation.

Limitations

Convenience sampling at a referral hospital limits how widely the acne prevalence estimate can be generalized. Perceived stigma was not independently measured. The cross-sectional design cannot determine whether anxiety preceded acne-related difficulties or followed them. The adjusted associations are exploratory, and their confidence intervals describe statistical uncertainty without eliminating sampling bias or other sources of error.

For breast cancer, the human sequencing component involved four tumor tissues; thousands of nuclei do not substitute for a larger patient sample. The reported description of increased lung metastasis provides no numerical effect size or uncertainty interval. Experimental findings do not establish the magnitude of an effect in patients. Neither study establishes patient-specific prediction or treatment efficacy.

What to watch

For acne, repeated diagnostic assessments across multiple centers could test whether scarring and poor treatment response precede phobic-anxiety onset rather than simply coexist with it.

For the cancer mechanism, confidence would rise if independent mouse experiments showed a reproducible reduction in the number or size of lung metastases after disrupting the proposed COPA-dependent pathway or exosomal RNA signal, with quantified effect sizes and uncertainty intervals. Failure to reproduce that change would weaken confidence.